Deep-Diving Into Mechanistic Insights of a Novel ADC Payload That Inhibits Protein Translation
- Describing preclinical development of a novel ADC payload targeting protein synthesis
- Evaluating how translation inhibitor ADCs elicit robust anti-tumor activity across a diverse range of tumor types in in vitro and in vivo investigation
- Spotlighting preclinical data to indicate a unique MoA among protein synthesis inhibitors that drives immunogenic cell death